Cadrenal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	33	26	10	-
Market Cap Growth	168.05%	168.05%	-	-
Enterprise Value	23	21	1	-
Last Close Price	18.46	14.49	11.10	-
PB Ratio	4.42	3.47	1.25	-
P/TBV Ratio	3.47	3.47	1.25	-
Debt / Equity Ratio	-	-	0.00	-0.11
Quick Ratio	3.75	3.75	10.21	0.02
Current Ratio	3.77	3.77	10.27	0.55
Return on Equity (ROE)	-140.78%	-140.78%	-780.59%	-
Return on Assets (ROA)	-73.49%	-73.49%	-102.62%	-
Return on Capital (ROIC)	-90.41%	-90.41%	-340.35%	-
Earnings Yield	-32.14%	-41.24%	-86.73%	-
FCF Yield	-22.22%	-28.51%	-36.67%	-
Buyback Yield / Dilution	-35.59%	-35.59%	-70.99%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q